Literature DB >> 32006217

Long-term stability of a three-dimensional dose verification system.

Motoharu Sasaki1, Hitoshi Ikushima2, Wataru Sugimoto3, Kenta Kitagawa4.   

Abstract

Recently, the number of patients undergoing intensity-modulated radiation therapy and volumetric modulated arc therapy has increased with the expansion of the adaptation site. However, it is necessary to improve the efficiency of time-consuming dose verification. Therefore, patient-specific quality assurance is expected to shift from dose verification using a conventional ionization chamber dosimeter and film to a three-dimensional dose verification system. However, caution is required when using a three-dimensional dose verification system, especially when it comes to the calibration of the detector. Calibration is performed regularly, but not all necessary verifications are done routinely. There are many uncertainties on how the sensitivity of the three-dimensional dose verification system changes over time. In this study, on the same day, when dose verification using a three-dimensional system for one head and neck case was performed, dose verification using a conventional ionization chamber dosimeter and film was also performed once every two months, for 2 years. From the results of the absolute dose and dose distribution verification using the ionization chamber dosimeter and Gafchromic film, the output of the linear accelerator, mechanical accuracy and precision were secured. From the results of the three-dimensional dose verification system, when the distance to agreement was evaluated at 2 mm and 3 mm, and gamma analysis was performed at 2 mm/2% and 3 mm/3%, the passing rate was almost 100%, and a sensitivity change in 2 years was not observed.

Entities:  

Keywords:  Long-term stability; Patient-specific QA; Three-dimensional dose verification system; VMAT

Year:  2020        PMID: 32006217     DOI: 10.1007/s12194-020-00554-7

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  6 in total

1.  [The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)].

Authors:  N Hodapp
Journal:  Strahlenther Onkol       Date:  2012-01       Impact factor: 3.621

2.  Task Group 142 report: quality assurance of medical accelerators.

Authors:  Eric E Klein; Joseph Hanley; John Bayouth; Fang-Fang Yin; William Simon; Sean Dresser; Christopher Serago; Francisco Aguirre; Lijun Ma; Bijan Arjomandy; Chihray Liu; Carlos Sandin; Todd Holmes
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

3.  Comparison of three commercial dosimetric systems in detecting clinically significant VMAT delivery errors.

Authors:  Sankar Arumugam; Aitang Xing; Tony Young; David Thwaites; Lois Holloway
Journal:  Phys Med       Date:  2016-10-04       Impact factor: 2.685

4.  Dose impact of rectal gas on prostatic IMRT and VMAT.

Authors:  Motoharu Sasaki; Hitoshi Ikushima; Masahide Tominaga; Takeshi Kamomae; Taro Kishi; Masataka Oita; Masafumi Harada
Journal:  Jpn J Radiol       Date:  2015-11-17       Impact factor: 2.374

5.  Reproducibility in patient-specific IMRT QA.

Authors:  Elizabeth M McKenzie; Peter A Balter; Francesco C Stingo; Jimmy Jones; David S Followill; Stephen F Kry
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

6.  Evaluation of the sensitivity of two 3D diode array dosimetry systems to setup error for quality assurance (QA) of volumetric-modulated arc therapy (VMAT).

Authors:  Guangjun Li; Sen Bai; Nianyong Chen; Lansdale Henderson; Kui Wu; Jianghong Xiao; Yingjie Zhang; Qingfeng Jiang; Xiaoqin Jiang
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

  6 in total
  1 in total

1.  Simplification of head and neck volumetric modulated arc therapy patient-specific quality assurance, using a Delta4 PT.

Authors:  Motoharu Sasaki; Wataru Sugimoto; Hitoshi Ikushima
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.